Roberts Brandi
SEC CIK 1516354 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | CFO | 397.9K | — | $135.7K | 5 | 2026-02-03 | 2026-09-14 |
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 08:30 | 2026-09-14 | DFTX | Definium Therapeutics, Inc. | Roberts Brandi | CFO | A - Grant | $0.00 | +125.0K | 397.9K | +46% | $0 | |
| 2026-08-12 08:30 | 2026-08-12 | DFTX | Definium Therapeutics, Inc. | Roberts Brandi | CFO | A - Grant | $0.00 | +62.5K | 272.0K | +30% | $0 | |
| T | 2026-06-26 16:30 | 2026-06-25 | DFTX | Definium Therapeutics, Inc. | Roberts Brandi | CFO | S - Sale | $45.03 | -3,013 | 209.5K | -1% | -$135.7K |
| 2026-06-22 09:45 | 2026-06-22 | DFTX | Definium Therapeutics, Inc. | Roberts Brandi | CFO | A - Grant | $0.00 | +62.5K | 212.5K | +42% | $0 | |
| 2026-02-05 | 2026-02-03 | DFTX | Definium Therapeutics, Inc. | Roberts Brandi | CFO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations